Ubs Group Ag Centogene N.V. Transaction History

Ubs Group Ag

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.02 - $1.47 $1,131 - $1,630	1,109 New	1,109 $1,000
Q4 2022 Feb 08, 2023	BUY	$0.72 - $0.97 $595 - $802	827 New	827 $0
Q2 2022 Aug 10, 2022	BUY	$2.06 - $4.25 $284 - $586	138 New	138 $0
Q4 2021 Feb 14, 2022	SELL	$4.56 - $10.56 $305 - $707	-67 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.9 - $11.72 $1,405 - $1,664	-142 Reduced 67.94%	67 $1,000

Q2 2021 Aug 13, 2021	SELL	$9.02 - $12.93 $14,648 - $20,998	-1,624 Reduced 88.6%	209 $2,000
Q1 2021 May 12, 2021	BUY	$10.56 - $13.94 $3,220 - $4,251	305 Added 19.96%	1,833 $22,000
Q4 2020 Feb 11, 2021	BUY	$9.44 - $13.3 $11,743 - $16,545	1,244 Added 438.03%	1,528 $16,000
Q3 2020 Nov 12, 2020	SELL	$9.3 - $25.16 $10,006 - $27,072	-1,076 Reduced 79.12%	284 $3,000
Q2 2020 Jul 31, 2020	SELL	$15.99 - $22.88 $8,938 - $12,789	-559 Reduced 29.13%	1,360 $31,000
Q1 2020 May 01, 2020	SELL	$9.76 - $23.8 $17,733 - $43,244	-1,817 Reduced 48.63%	1,919 $38,000
Q4 2019 Feb 14, 2020	BUY	$8.1 - $14.6 $30,261 - $54,545	3,736 New	3,736 $38,000

2.14M

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.3M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.